Stockreport

Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight [Yahoo! Finance]

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Research into microbiome-based therapies, such as probiotics, prebiotics, and fecal microbiota transplants (FMT), is paving the way for novel treatments. By targeting th [Read more]